IPCA Labs 4Q Net Income Falls 94 Percent on U.S. FDA AlertsBhuma Shrivastava
IPCA Laboratories posts 4Q net income of 77.9 million rupees compared with 1.37 billion rupees a year earlier: co. filing Link
- Lower profit due to import alerts issued by U.S.’s Food and Drug Administration on three manufacturing sites, foreign currency fluctuations and reduced sales of anti-malarial drugs: filing
- Co. posts 4Q net sales of 6.28 billion rupees versus 7.5 billion rupees a year earlier
- Board recommends dividend of one rupee/share
- NOTE: IPCA Labs Shares Slump After FDA Import Alert on Two More Plants Link
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.